Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease

Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease

http://www.wikidata.org/entity/Q26999066

about

Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Compounds from gum ammoniacum with acetylcholinesterase inhibitory activity.Molecular, cellular and circuit basis of cholinergic modulation of pain.

P2860

Q37559812-054D07FE-D05B-4D15-BF13-870BEB422F3C Q41776778-50A11252-FD77-4ADA-B96F-7AFFCF4160A6 Q43061482-AB404CB9-1250-42B4-8FD5-8103E565ECC6

P2860

Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease

http://www.wikidata.org/entity/Q26999066

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@ast

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@en

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@nl

type

label

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@ast

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@en

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@nl

prefLabel

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@ast

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@en

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@nl

P1433

Q26999066-8C02ADFB-502C-4D7E-A1D5-FD8D5413C2EF

P1476

Q26999066-04275523-4AAE-4F9E-A824-01178B359DA0

P2093

Q26999066-51E9E25F-B9FC-4A14-AED8-9231F695C676

Q26999066-95BAF691-17B1-47E4-88E4-FFD2C21A7A42

Q26999066-FBB88401-C4A2-4114-9A3F-D8E50CFE5FE0

P2860

Q26999066-01ED4268-A426-4AC6-9F68-744EE26BC441

Q26999066-02637C4C-B1FA-4509-990A-57B49C5C478D

Q26999066-034406BE-F21E-4B02-86EE-12BF3D91B58A

Q26999066-04A04A49-3DE8-4E45-88EF-91DA8DB8E7A5

Q26999066-078847BC-7F5D-4886-A8BB-5CE96AF83549

Q26999066-0BFE346A-0ADB-4655-AE62-4E43C947CA90

Q26999066-0ECB1129-8BC4-4644-9947-D8D195C65BE6

Q26999066-12694674-3CF1-4D7E-9A0D-A4339F792DEC

Q26999066-13FFDB1B-4835-48E5-ABDE-12E5CDED3BC8

Q26999066-14BF55A6-6304-4418-BDC3-6198C1A22D9F

P304

Q26999066-8061280B-3CD8-411C-8509-F0A3CDB7A5A7

P31

Q26999066-0FE1839A-C1BF-4AC5-BF7E-F108F2CD0998

P356

Q26999066-788C8CA8-0D96-4AF5-B9AC-FD8FD36A3645

P407

Q26999066-D812D232-03E5-4516-BAE7-38454E677212

P433

Q26999066-867A90B0-C469-43C7-A46B-3CF2E893AA73

P478

Q26999066-0D5842D9-6471-4A33-A546-DC55219293B1

P577

Q26999066-81B5D053-FE1E-435E-AC48-F0DCF882D4CE

P698

Q26999066-9392691B-9568-47BE-90D5-2480A1D95456

P921

Q26999066-85095B42-E3A0-49FE-8727-E0C709957CC4

Q26999066-8db52c24-eebb-4fd9-bf52-f4e211f0b7a7

Q26999066-966A5A5C-E585-4B2E-ACD4-DBEC2D98BA68

P932

Q26999066-3A5BE985-417A-4B40-8DAA-AAC47A988A01

P356

1389557511313030012

P1433

Mini-Reviews in Medicinal Chemistry

P1476

Cholinergic modulation by opio ...... ication to Alzheimer's disease

@en

P2093

Coop A

http://www.w3.org/2001/XMLSchema#string

Cunningham CW

http://www.w3.org/2001/XMLSchema#string

Motel WC

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer Disease in the US Population

Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology

Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches

Predicting new molecular targets for known drugs

75 years of opioid research: the exciting but vain quest for the Holy Grail

A new and rapid colorimetric determination of acetylcholinesterase activity

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution

Galanthamine and Non-competitive Inhibitor Binding to ACh-binding Protein: Evidence for a Binding Site on Non-α-subunit Interfaces of Heteromeric Neuronal Nicotinic Receptors

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A

The cholinergic hypothesis of geriatric memory dysfunction

P304

456-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1389557511313030012

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22931533

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3816933

http://www.w3.org/2001/XMLSchema#string